3 Important Things to Know About Social Security in 2026

Social Security beneficiaries receive a 2.8% COLA for 2026, but rising Medicare costs—most notably the Medicare Part B standard premium increase from $185 to $202.90 (a $17.90 monthly rise)—and potential higher Medicare Advantage/Part D out-of-pocket costs could materially erode that boost. Full retirement age has shifted to 67 for those born in 1960 or later, so filing at 66 in 2026 would permanently reduce benefits (about a 6.67% reduction for claiming one year early), while Trustees project the OASI Trust Fund can pay full benefits only through 2033 (or 2034 if combined with DI), increasing the likelihood that lawmakers will need to consider benefit or funding changes and prompting a need for higher personal savings.

Analysis

Market structure: Rising Part B premiums ($17.90/month increase vs COLA 2.8%) is a small but material hit to retiree disposable income that favors healthcare insurers with Medicare Advantage scale (e.g., UNH, HUM, CVS/Aetna) through enrollment growth, while pressuring consumer discretionary demand (XLY) and small-cap retailers. Drug-tier shifts and higher out-of-pocket copays create pricing pressure on PBMs and specialty pharma margins, and increase political/regulatory scrutiny on MA payment rates.

Risk assessment: Near-term (days–months) risk is muted but measurable: enrollment flows and Q1 2026 guidance could swing earnings for MA insurers; medium-term (6–18 months) tail risk is a legislative shock (benefit cuts, payroll tax hikes) around the 2033 insolvency timeline that could trigger a consumption shock and higher long-term Treasury issuance. Hidden dependencies include state Medicaid backstops and PBM rebate mechanics; catalysts to monitor are CMS payment notices, Trustee reports, and midterm election outcomes.

Trade implications: Favor selective healthcare insurers and MA exposure (ask size 1–2% positions) while underweighting discretionary retail by 3–5% into Q2 2026. Use protective options (3–9 month put spreads) on HUM/HLS insurers to hedge policy headlines; rotate 3–12% of cash into short-duration Treasuries/T-bills to lock current yields ahead of fiscal-driven rate moves.

Contrarian angles: The market underprices the probability of a legislative fix that avoids sharp benefit cuts (e.g., payroll tax tweaks, phased reforms), which would relieve downside for financials and annuity writers (AIG, BLK). Also, overbuying MA exposure could invite regulatory clampdowns — prefer diversified exposure (XLV) and avoid concentrated levered bets until CMS rate clarity in next 60–120 days.

Key Decisions for Investors

• Establish a 1–1.5% long position in UnitedHealth (UNH) over 6–12 months to capture Medicare Advantage enrollment tailwinds; set a 12% stop-loss and reduce to 0.5% if CMS issues unfavorable payment changes in next 60 days.
• Reduce consumer discretionary exposure (XLY or individual retailers) by 3–5% of portfolio within 30 days; alternatively buy 3-month put protection on XLY (10% out-of-the-money) sized to cover the reduced allocation.
• Initiate a 0.5% notional 6–9 month put spread on Humana (HUM) as a hedge against regulatory/payment risk (sell a nearer strike, buy a farther OTM strike) and re-evaluate after CMS announcements or the next Trustees update.
• Reallocate 3–5% of portfolio to short-duration Treasuries or T-bills (3–12 month) immediately to lock current yields; if 10-yr Treasury breaks above 3.75% then extend duration to 5–7 years by up to an additional 2% allocation.
• If Congress proposes payroll tax increases or explicit benefit reductions (monitor legislative calendar and Trustees’ signals over next 60–120 days), deploy a 0.75–1% tactical long in BlackRock (BLK) and AIG (annuity exposure) anticipating higher demand for managed/guaranteed retirement solutions.